封面
市場調查報告書
商品編碼
1424302

醫用人造材料市場:按產品類型、按應用、按最終用戶、按地區

Medical Engineered Materials Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球醫用人造材料市場預計將從2023年的196.6億美元增加到2030年的501.1億美元,預測期內複合年成長率為14.3%。

報告範圍 報告詳情
基準年 2022年 2023/2024年市場規模 196.6億美元
實際資料 2018-2021 預測期 2023-2030
2023/2024-2030/2031預測期複合年成長率 14.30% 2030/2031價值預測 501.1億美元
圖 1. 2023 年按地區分類的醫用人造材料全球市場佔有率(%)
醫療工程材料市場-IMG1

醫用工程材料在醫療產業中發揮著重要作用,為廣泛的應用提供創新的解決方案。這些材料經過專門設計,以滿足醫療設備、植入和設備的獨特要求。它們具有卓越的強度、耐用性和生物相容性,確保安全有效的醫療解決方案。材料科學和工程的重大進步擴大了陶瓷、金屬、聚合物和複合材料等材料在醫學中的使用。新型生物工程材料正在開發中,可以密切模仿人體組織並有助於組織再生。這些進步是由醫療程序和治療日益複雜以及改善患者治療效果的需求所推動的。總體而言,醫療工程材料產業在開發創新材料解決方案以將醫療保健提升到新水平方面發揮關鍵作用。

市場動態:

全球醫用人造材料市場的成長受到多種因素的推動。心血管疾病、糖尿病和癌症等慢性疾病的日益普及預計將推動對醫療設備和植入的需求。這些材料具有生物相容性、耐用性和彈性等優異特性,使其對於先進醫療設備的開發至關重要。全球老年人口的增加正在推動市場成長。醫用人造材料的使用是必要的,因為老年人更容易患慢性病,需要專門的醫療。此外,材料科學的技術進步,例如基於奈米技術的生物基材料和塗料的開發,正在進一步推動市場成長。

然而,市場面臨一些挑戰。美國食品藥物管理局(FDA) 等監管機構實施的嚴格法規和品質標準可能成為市場進入者的障礙。遵守這些法規並獲得新材料的監管核准既耗時又昂貴。此外,與醫用人造材料的開發和製造相關的高成本可能會抑制因素市場成長。

本研究的主要特點

  • 本研究報告對全球醫用人造材料市場進行了詳細分析,並提供了以2022年為基準年的預測期(2023-2030年)的市場規模和年複合成長率(CAGR%)。
  • 它還闡明了各個細分市場的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數,介紹了全球醫用人造材料市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球醫用人造材料市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
  • 透過用於分析全球醫用人造材料市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章全球醫療材料市場 - 冠狀冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章全球醫療材料市場,依產品類型,2018-2030

  • 介紹
  • 金屬生物材料
  • 陶瓷生物材料
  • 高分子生物材料
  • 天然生物材料
  • 複合生物材料
  • 其他

第6章 全球醫療材料市場,依應用分類,2018-2030

  • 介紹
  • 心血管
  • 整形外科
  • 牙科
  • 整形外科
  • 創傷治療
  • 神經學的
  • 其他

第7章 全球醫療材料市場(依最終使用者),2018-2030

  • 介紹
  • 醫院
  • 診所
  • 研究機構
  • 其他

第8章2018-2030年全球醫療材料市場(按地區)

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲

第9章 中東/非洲

    • 2019-2030 年市場規模與按產品類型預測、與前一年同期比較成長率
    • 2019-2030 年市場規模與應用預測、與前一年同期比較成長率
    • 2019-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
    • 2019-2030年各國市場規模及預測、與前一年同期比較成長率
  • 海灣合作理事會國家
  • 以色列
  • 南非
  • 中部非洲
  • 北非
  • 其他中東地區

第10章競爭形勢

  • Evonik Industries AG
  • Covestro AG
  • BASF SE
  • Solvay
  • SABIC
  • Trelleborg AB
  • DSM
  • Celanese Corporation
  • DuPont de Nemours Inc.
  • Others

第11章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6308

Global medical engineered materials market is expected to reach US$ 50.11 Bn by 2030, from US$ 19.66 Bn in 2023, exhibiting a CAGR of 14.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 19.66 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 14.30% 2030/2031 Value Projection: US$ 50.11 Bn
Figure 1. Global Medical Engineered Materials Market Share (%), By Region, 2023
Medical Engineered Materials Market - IMG1

Medical engineered materials play a crucial role in the healthcare industry, and provides innovative solutions for a wide range of applications. These materials are specifically designed to meet the unique requirements of medical devices, implants, and equipment. These offer exceptional strength, durability, and biocompatibility, ensuring safe and effective healthcare solutions. There has been significant advancement in materials science and engineering which has expanded the use of materials like ceramics, metals, polymers, and composites in healthcare. Newer bioengineered materials are being developed that can closely mimic human tissues and aid in tissue regeneration. The advances are driven by the need for improved patient outcomes along with increasing complexity of medical procedures and treatments. Overall, the medical engineered materials industry plays a crucial role in developing innovative materials solutions that can elevate healthcare to the next level.

Market Dynamics:

Global medical engineered materials market growth is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and cancer is expected to boost demand for medical devices and implants. These materials offer exceptional properties including biocompatibility, durability, and flexibility, which are crucial in the development of advanced medical devices. Rising geriatric population worldwide is contributing to the market growth. The elderly population is more susceptible to chronic diseases and requires specialized medical treatments, which necessitate the use of medical engineered materials. Moreover, technological advancements in material science, such as the development of bio-based materials and nanotechnology-based coatings, are further driving market growth.

However, the market faces few challenges. Stringent regulations and quality standards imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), can pose hurdles for market players. Compliance with these regulations and obtaining regulatory approvals for new materials can be time-consuming and costly. Furthermore, the high cost associated with the development and manufacturing of medical engineered materials can act as a restraint for market growth.

Key features of the study:

  • This report provides in-depth analysis of the global medical engineered materials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical engineered materials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Evonik Industries AG, Covestro AG, BASF SE, Solvay, SABIC, Trelleborg AB, DSM, Celanese Corporation, DuPont de Nemours Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical engineered materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical engineered materials market

Medical Engineered Materials Market Detailed Segmentation:

  • By Product Type
    • Metallic Biomaterials
    • Ceramics Biomaterials
    • Polymeric Biomaterials
    • Natural Biomaterials
    • Composites Biomaterials
    • Others
  • By Application
    • Cardiovascular
    • Orthopedic
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Neuro-logical
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Research Institutions
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Top companies in Global Medical Engineered Materials Market:
    • Evonik Industries AG
    • Covestro AG
    • BASF SE
    • Solvay
    • SABIC
    • Trelleborg AB
    • DSM
    • Celanese Corporation
    • DuPont de Nemours Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Medical Engineered Materials Market, By Product Type
    • Medical Engineered Materials Market, By Application
    • Medical Engineered Materials Market, By End User
    • Medical Engineered Materials Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of chronic diseases
    • Stringent clinical & regulatory requirements
    • Applications in personalized medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Medical Engineered Materials Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Medical Engineered Materials Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Ceramics Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Composites Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030, (US$ Bn)

6. Global Medical Engineered Materials Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Neuro-logical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)

7. Global Medical Engineered Materials Market , By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)

8. Global Medical Engineered Materials Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America

9. Middle East & Africa

  • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • South Africa
  • Central Africa
  • North Africa
  • Rest of Middle East

10. Competitive Landscape

  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Solvay
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SABIC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trelleborg AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DuPont de Nemours Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us